[Webinar] Multi-Criteria Decision Analysis: Can It Help Make Value Assessment More Patient-Centered?

October 12, 2020

Researchers, value assessors, and the patient community agree that traditional means of value assessment often do not factor in the many dimensions of value important to patients. Researchers have identified multi-criteria decision analysis (MCDA) as one potential approach to provide a more comprehensive measure of value.

Tune in on Oct. 15 from 11 a.m. – 12 p.m. ET for a webinar, held in conjunction with release of a white paper summarizing findings from a Roundtable on Patient-Centered Multi-Criteria Decision Analysis, co-hosted by the National Health Council (NHC) and National Pharmaceutical Council (NPC) earlier this year. Topics include:

  • What is MCDA?
  • Can MCDA help make value assessment more patient-centered?
  • What are the opportunities and challenges associated with developing patient-centered MCDA?

Moderator: Elisabeth Oehrlein, PhD, MS, Senior Director, Research and Programs, National Health Council


  • Kimberly Westrich, MA, Vice President for Health Services Research, National Pharmaceutical Council
  • R. Brett McQueen, PhD, Assistant Professor, Co-Investigator, pValue, University of Colorado School of Pharmacy
  • Jennifer Bright, MPA, Executive Director, Innovation and Value Initiative
  • Anna Hyde, MA, Vice President of Advocacy and Access, Arthritis Foundation

Register here.

Share This Story!